Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

FD acquires QuantumKDB

12 Jan 2016 07:00

RNS Number : 5189L
First Derivatives PLC
12 January 2016
 

12 January 2016

 

First Derivatives plc

("FD", the "Company" or the "Group")

 

FD acquires QuantumKDB

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces that it has acquired the entire issued share capital of QuantumKDB (UK) Limited ("Quantum") for total consideration of up to £2.2m. The acquisition provides the Group with complementary consultancy expertise to support the growth of its Kx business and is expected to be earnings enhancing in the first full year following acquisition*.

 

Acquisition rationale

 

Quantum was founded in 2011 by its CEO Kieran Lucid and provides Kx consulting in the UK, US and Hong Kong. The majority of its clients operate in capital markets and the acquisition will strengthen the Group's relationship with certain key clients as well as adding to the existing customer base. Quantum has a total of 15 consultants with strong experience in Kx technology. In its latest financial year to 13 September 2015, Quantum reported profit before tax of £0.3m and had net assets of £0.25m at acquisition.

 

Terms of the Acquisition

 

The initial consideration for the acquisition is £1.7m of which £0.6m is payable in cash and £1.1m is payable through the issue of 72,940 new ordinary shares in FD (the "Consideration Shares"). Deferred consideration of up to £0.5m is payable on the achievement of certain targets on the 12 month anniversary of the acquisition.

 

Application has been made for the 72,940 Consideration Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 15 January 2016. The Consideration Shares will rank pari passu with the Company's existing ordinary shares in issue. Following this allotment, the total issued share capital of the Company will increase to 23,921,972 ordinary shares.

 

Kieran Lucid, Chief Executive Officer of Quantum, commented: "As the home of Kx technology, FD is a natural fit for us. We are joining at a time of rapid expansion in the Kx client base across industry sectors, as more and more clients appreciate the benefits of this technology that has dominated capital markets for more than 10 years. We are excited about drawing on the expertise we've gained to assist the Group in its ambitious plans for the future."

 

Brian Conlon, Chief Executive Officer of FD, commented: "We are experiencing increasing demand for Kx skills from existing and potential customers and the acquisition of Quantum will add to our existing capabilities and support our growth plans. We welcome its staff to the Group."

 

\* This statement does not constitute a profit forecast.

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAEFFFELKEAF
Date   Source Headline
2nd Feb 20229:33 amRNSHolding(s) in Company
20th Jan 20227:00 amRNSDirectorate Change
17th Jan 20227:00 amRNSDirector/PDMR Shareholding
31st Dec 202110:10 amRNSTotal Voting Rights
13th Dec 20212:59 pmRNSIssue of Equity
9th Dec 20219:40 amRNSDirector/PDMR Shareholding
1st Dec 20211:55 pmRNSHolding(s) in Company
30th Nov 202110:52 amRNSTotal Voting Rights
18th Nov 20217:00 amRNSAppointment of Adviser
15th Nov 20215:12 pmRNSIssue of Equity
9th Nov 20218:48 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSResults for the six months ended 31 August 2021
11th Oct 20217:00 amRNSHolding(s) in Company
6th Oct 20214:27 pmRNSHolding(s) in Company
6th Oct 20217:00 amRNSNotice of Results
1st Sep 20219:29 amRNSTotal Voting Rights
25th Aug 20215:37 pmRNSIssue of Equity
11th Aug 20217:00 amRNSLTIP Award
30th Jul 20217:00 amRNSDirectorate Change
8th Jul 20215:23 pmRNSResult of AGM
2nd Jul 202111:47 amRNSHolding(s) in Company
30th Jun 202112:16 pmRNSTotal Voting Rights
22nd Jun 20215:44 pmRNSIssue of Equity
15th Jun 20211:20 pmRNSHolding(s) in Company
14th Jun 20215:05 pmRNSHolding(s) in Company
8th Jun 20215:19 pmRNSNotice of AGM & Change of Name
1st Jun 202110:31 amRNSTotal Voting Rights
26th May 20214:06 pmRNSHolding(s) in Company
25th May 20216:08 pmRNSIssue of Equity
18th May 20217:00 amRNSFull Year Results
13th Apr 20217:00 amRNSTrading Update
31st Mar 202110:29 amRNSTotal Voting Rights
3rd Mar 20216:13 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAppointment of Eric Raab as KX CTO
1st Mar 20217:00 amRNSAppointment of Scott Matthews as CEO for MRP
26th Feb 20214:18 pmRNSIssue of Equity
26th Feb 20219:25 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPartial sale of Quantile Technologies holding
15th Feb 20214:28 pmRNSIssue of Equity
29th Jan 20219:59 amRNSTotal Voting Rights
25th Jan 20216:18 pmRNSIssue of Equity
31st Dec 202011:17 amRNSTotal Voting Rights
9th Dec 20207:00 amRNSDirectorate Change
8th Dec 202012:46 pmRNSIssue of Equity
30th Nov 20209:35 amRNSTotal Voting Rights
16th Nov 20203:21 pmRNSHolding(s) in Company
13th Nov 20204:08 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSResult of secondary placing
30th Oct 20201:30 pmRNSIssue of Equity
27th Oct 20207:00 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.